Research Professor at INSERM, Research Centre for Respiratory Diseases
Nathalie Heuzé-Vourc'h is a senior research scientist at The National Insitute of Biomedical Sciences in France and is leading a multidisciplinary team dedicated to "Aerosoltherapy and Biotherapeutics for Respiratory Diseases".
After graduating her Ph.D. in oncology in 2001, she trained in the division of pulmonary and critical care medicine at UCLA, California. She gained interest in biotherapeutics working in a start-up (Agensys Inc., California) developing anticancer antibodies.
She has published more than 60 articles so far and is interested in the multifacets of biotherapeutics inhalation. She often serves as a scientific expert for the European Commission and for biotechs. She is a member of the Scientific committee of the french Health Technologies Institute.
The biological barriers to consider for the development of inhaled biotherapeutics
- Understanding the particularity of biotherapeutics inhalation
- Passage of inhaled biotherapeutics from the airways into the systemic circulation
- Biological barriers (mucus, macrophages,...) that must be considered for the development of inhaled biotherapeutics